Wayne Gordon
General Counsel at A-Bio Pharma Pte Ltd.
Profile
Wayne Gordon is Director of Regulatory Affairs and Quality for A-Bio Pharma Pte Ltd.
Prior to joining A-Bio Pharma in January 2008, he was a Senior Director of Quality for Tanox, Inc. Dr. A-Bio Pharma received a PhD in Physiology and Biophysics from the University of Illinois.
Wayne Gordon active positions
Companies | Position | Start |
---|---|---|
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | General Counsel | 31/12/2007 |
Former positions of Wayne Gordon
Companies | Position | End |
---|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Corporate Officer/Principal | - |
Training of Wayne Gordon
University of Illinois | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
A-Bio Pharma Pte Ltd.
A-Bio Pharma Pte Ltd. Miscellaneous Commercial ServicesCommercial Services A-Bio Pharma Pte Ltd. provides pharmaceutical research services. It offers manufacturing solutions for mammalian cell culture systems, including process development, optimization, manufacturing scale-up, GMP production, quality control and regulatory compliance. The company was founded in 2001 and is headquartered in Singapore. | Commercial Services |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
- Stock Market
- Insiders
- Wayne Gordon